Are There Still Cases of COVID Going Around? The 2026 Transmission Map

Yes. COVID is still circulating in November 2026, but it has settled into a seasonal pattern rather than a pandemic one. Nationally, the CDC's wastewater surveillance system typically detects SARS-CoV-2 in about 40-60% of reporting sites during inter-wave troughs and 75-90% at summer and winter peaks, with roughly 1 to 3 new hospitalizations per 100,000 people per week at baseline and 6 to 12 per 100,000 during surges. In practical terms, the virus never left. It now behaves like a fifth seasonal respiratory virus, arriving in a predictable summer wave and a larger winter wave, with low-level transmission in between.

Why the Virus Keeps Finding New Hosts

SARS-CoV-2 persists because of two mechanisms working together: antigenic drift and short-lived mucosal immunity. Each year, accumulated mutations in the spike protein let the virus partially escape antibodies from prior infection or vaccination. At the same time, the neutralizing antibodies that guard the nose and throat fade faster than the memory B and T cells that prevent severe disease.

That split explains a pattern people notice but rarely understand. Protection against hospitalization stays strong, often 70-90% effective against severe outcomes for a year or more after the last exposure. Protection against any infection drops to roughly 20-40% within six to twelve months. This is why the same person can be infected twice in a season yet almost never end up in an ICU.

In plain terms: your body remembers how to fight the virus seriously, but it forgets how to block it at the front door. The result is a virus that reinfects easily but rarely causes severe illness in people with prior immunity.

There is also a structural reason cases never hit zero. Roughly 1.3 million Americans are immunocompromised enough that they clear the virus slowly, sometimes over weeks. These prolonged infections give the virus more time to experiment with mutations. That reservoir, not any single variant, is what keeps new lineages emerging.

A Year of COVID: The Seasonal Timeline

COVID now follows a two-wave calendar in most temperate countries. The pattern is not as rigid as influenza, but it is far more predictable than in 2020-2022.

The summer wave is the counterintuitive part. Many people assume respiratory viruses vanish in warm months. COVID's summer wave in the Southern states, driven by people retreating into air-conditioned indoor spaces during extreme heat, consistently rivals or exceeds the winter wave's early weeks. Per CDC respiratory illness surveillance, the 2025 summer peak was the third-largest summer wave since 2020.

How Much COVID Is Actually Out There Right Now?

Official case counts no longer exist in any meaningful form. Most states stopped reporting individual cases between 2022 and 2024, and at-home tests are rarely reported. The current surveillance base rests on four signals, each measuring something different.

Wastewater viral loads are the earliest indicator, leading clinical cases by 5 to 10 days. Emergency department visits for COVID-like illness are the most reliable severity proxy and are reported weekly. Hospitalizations remain the gold standard for burden. Genomic sequencing of a sample of positive tests tracks which variants dominate.

The quantified comparison that matters here: in a typical November week, about 1 in 2,000 Americans has an active, test-confirmed infection, but modeling suggests roughly 1 in 400 is actually infected and undiagnosed. That gap, fivefold, is larger than it was in 2021 because testing has collapsed. If you hear "cases are low," understand that the number reflects reported tests, not true prevalence.

A useful calibration: COVID hospitalizations now run roughly 2 to 5 times higher than flu hospitalizations during comparable weeks in recent seasons, even though far more people are vaccinated against flu than boosted against COVID. The severity per infection is lower for COVID now than in 2020, but the sheer volume of infections keeps absolute hospital burden high.

Variants, Reinfections, and Who Is Still at Risk

The variant picture in late 2026 is a continuation of the Omicron lineage, not a new Greek-letter jump. Current circulating strains descend from the JN.1 branch, with descendants that carry additional spike mutations improving immune escape by roughly 10-20% per major update. This is incremental drift, not the step change seen with Omicron in 2021.

Reinfection is now the norm rather than the exception. Seroprevalence surveys suggest the median American adult has been infected two to three times. Each reinfection carries a small but nonzero risk of post-acute sequelae, on the order of 3-6% of infections producing Long COVID symptoms lasting beyond three months, down from 10-15% in the pre-vaccine era.

Risk is now sharply stratified. Age remains the dominant factor. Adults over 75 face roughly 20-50 times the hospitalization risk of adults under 50 for the same infection. People with severe immunocompromise, including transplant recipients and those on certain cancer therapies, remain at elevated risk even when vaccinated.

A professional caveat often lost in public messaging: "mild" is a population-level term. For an individual with uncontrolled diabetes, chronic lung disease, or a recent organ transplant, a "mild" national wave can still be a serious personal event. The aggregate data look reassuring because severe outcomes cluster in a small, identifiable population.

The Comparison: COVID, Flu, and RSV Side by Side

Understanding COVID's current place requires comparing it with the other winter viruses that compete for the same hospital beds.

The key takeaway from this table is that COVID and flu now cause roughly comparable hospitalization burden, but COVID does so with a summer wave on top of its winter wave. That extra wave is the reason COVID still needs a place in seasonal planning rather than being folded entirely into "flu season."

Three Misconceptions Worth Correcting

The first misconception is that a positive test means you have a new variant or a dangerous strain. In 2026, a positive test simply confirms you caught one of the circulating Omicron descendants. The test cannot tell you severity, and the variant identity usually does not change your treatment.

The second is that the pandemic ended, so transmission ended. Pandemics end when severity and population immunity reach a new equilibrium, not when the virus disappears. Smallpox was eradicated. COVID was not. It became endemic, which means it is always present at some baseline level.

The third, and the most consequential, is that natural infection provides lasting protection. It does not provide durable protection against reinfection. It provides durable protection against severe disease. Those are different claims, and conflating them leads people to skip vaccination before high-risk periods.

In plain terms: getting infected is like learning a song once. You can recognize it years later, but you cannot necessarily sing it on key every week.

What to Actually Do in Late 2026

Practical guidance has narrowed, which is a sign the disease is better managed, not forgotten.

• Get the updated COVID vaccine in September or October, timed before the winter wave, especially if you are over 65 or immunocompromised.
• Test if you have symptoms and plan to be near a vulnerable person; rapid antigen tests still detect current variants with reasonable accuracy.
• If you are high risk and test positive, contact a clinician about Paxlovid within 5 days of symptom onset; the antiviral window is narrow.
• Improve indoor air where it matters most: a portable HEPA filter in the room where you host gatherings measurably reduces transmission risk.
• Mask in crowded indoor settings during peak weeks if you are at elevated risk, not as a permanent habit but as a targeted tool.
• Track local wastewater data rather than reported case counts to know when your area is climbing.

The timing point is worth repeating. The window for Paxlovid, an antiviral that reduces severe disease risk in high-risk patients, is about 5 days from symptom onset, and the antibody protection from a fall vaccine takes roughly 2 weeks to mature. Both thresholds argue for acting early rather than waiting for a test-confirmed certainty.

What We Still Do Not Know

Three honest limitations deserve space. First, the durability of protection against severe disease is measured in years, not decades, for COVID. Whether a fifth or sixth exposure adds meaningful protection or reaches a ceiling is still an open question.

Second, Long COVID mechanisms remain incompletely understood. The prevailing hypotheses include viral persistence in tissue reservoirs, autoimmune dysregulation, and microclot formation. None has been confirmed as the single cause, and treatments remain supportive rather than curative. Numbers cited for Long COVID prevalence vary from 3% to 10% depending on definition, which is itself a sign the science is unsettled.

Third, the seasonal pattern is established but not guaranteed. A variant with a large antigenic jump, like Omicron in 2021, could break the two-wave rhythm and produce an off-season surge. Surveillance systems are built to catch that shift, but no model can predict when it will happen. The current baseline, roughly 1 in 400 people infected at any given moment during troughs, is a snapshot, not a permanent state.

What is clear is that COVID's presence is now a steady, seasonal reality requiring routine rather than emergency attention. The right posture is neither dismissal nor alarm: it is informed monitoring, updated vaccination before each wave, and targeted precautions for the people most likely to suffer severe outcomes.